Login / Signup
The Janus kinase 1/2 inhibitor ruxolitinib in COVID-19.
Alessandro Gozzetti
Enrico Capochiani
Monica Bocchia
Published in:
Leukemia (2020)
Keyphrases
</>
coronavirus disease
sars cov
respiratory syndrome coronavirus